Making AI powered drug design as simple as using a spreadsheet
Born at the epicentre of Biotech Innovation
Founded by a team of researchers at the University of Cambridge in 2019, DeepMirror recognised early that while many spoke of AI's potential to "accelerate discovery", real-world examples were sparse.
From day 1, our guiding principle has been to demystify complex AI, rendering it both accessible and invaluable to scientists across the spectrum.
Whether collaborating with intimate academic teams or partnering with global biopharma giants, our commitment remains steadfast: to bring our vision of accessible AI to life.
Today, as pioneers at the crossroads of biology, physics, and machine learning, we're fortunate to be backed by a network of forward-thinking investors. Reach out at email@example.com.
We make AI powered drug design as simple as browsing the web and empower every biopharma team to find better drugs faster. Ultimately, powering the century of biology and elevating health for all.
Leaders at the interface of Biology, Physics, Machine Learning and Business.
With an unwavering drive to deliver and a proven track record.
We aim to be an inspiring workplace that fosters a strong sense of agency through collaboration and growth
We want to be an inclusive and diverse workplace where every voice is heard and we become greater together than we are as individuals
We hold ourselves to the highest ethical and responsibility standards to leave a lasting positive impact on the world of life sciences and beyond